Hepatitis B Virus-Hepatocyte Interactions and Innate Immune Responses

Experimental Models and Molecular Mechanisms

Emmanuel Thomas, Thomas F. Baumert

Research output: Contribution to journalArticle

Abstract

Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide. While current therapeutic approaches can efficiently control viral infection, efficient curative antivirals are absent. The understanding of virus-hepatocyte interactions and sensing of viral infection is an important prerequisite for the development of novel antiviral therapies for cure. Hepatocyte intrinsic innate immunity provides a rapid first line of defense to combat viral infection through the upregulation of antiviral and inflammatory genes. However, the functional relevance of many of these antiviral signaling pathways in the liver and their role in HBV pathogenesis is still only partially understood. The recent identification of intracellular RNA and DNA sensing pathways and their involvement in disease biology, including viral pathogenesis and carcinogenesis, is currently transforming our understanding of virus-host interactions. Here the authors review the current knowledge on intrinsic antiviral innate immune responses including the role of viral nucleic acid sensing pathways in the liver. Since HBV has been designated as a stealth virus, the study of the impact of HBV on signaling pathways in the hepatocyte is of significant interest to understand viral pathogenesis. Characterizing the mechanism underlying these HBV-host interactions and targeting related pathways to enhance antiviral innate responses may open new strategies to trigger noncytopathic clearance of covalently closed circular DNA to ultimately cure patients with chronic HBV infection.

Original languageEnglish (US)
Pages (from-to)301-314
Number of pages14
JournalSeminars in Liver Disease
Volume39
Issue number3
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Innate Immunity
Hepatitis B virus
Antiviral Agents
Virus Diseases
Hepatocytes
Theoretical Models
Chronic Hepatitis B
Viruses
Circular DNA
Liver
Liver Neoplasms
Nucleic Acids
Liver Diseases
Carcinogenesis
Up-Regulation
RNA
DNA
Therapeutics
Genes

Keywords

  • antiviral immune responses
  • chemokines
  • cytokines
  • hepatitis b virus
  • host defense
  • intrinsic innate responses
  • IRF3
  • nuclear factor-kappaB
  • pattern recognition receptor

ASJC Scopus subject areas

  • Hepatology

Cite this

Hepatitis B Virus-Hepatocyte Interactions and Innate Immune Responses : Experimental Models and Molecular Mechanisms. / Thomas, Emmanuel; Baumert, Thomas F.

In: Seminars in Liver Disease, Vol. 39, No. 3, 01.01.2019, p. 301-314.

Research output: Contribution to journalArticle

@article{21408e4172df4cf8845fa82b507f4d68,
title = "Hepatitis B Virus-Hepatocyte Interactions and Innate Immune Responses: Experimental Models and Molecular Mechanisms",
abstract = "Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide. While current therapeutic approaches can efficiently control viral infection, efficient curative antivirals are absent. The understanding of virus-hepatocyte interactions and sensing of viral infection is an important prerequisite for the development of novel antiviral therapies for cure. Hepatocyte intrinsic innate immunity provides a rapid first line of defense to combat viral infection through the upregulation of antiviral and inflammatory genes. However, the functional relevance of many of these antiviral signaling pathways in the liver and their role in HBV pathogenesis is still only partially understood. The recent identification of intracellular RNA and DNA sensing pathways and their involvement in disease biology, including viral pathogenesis and carcinogenesis, is currently transforming our understanding of virus-host interactions. Here the authors review the current knowledge on intrinsic antiviral innate immune responses including the role of viral nucleic acid sensing pathways in the liver. Since HBV has been designated as a stealth virus, the study of the impact of HBV on signaling pathways in the hepatocyte is of significant interest to understand viral pathogenesis. Characterizing the mechanism underlying these HBV-host interactions and targeting related pathways to enhance antiviral innate responses may open new strategies to trigger noncytopathic clearance of covalently closed circular DNA to ultimately cure patients with chronic HBV infection.",
keywords = "antiviral immune responses, chemokines, cytokines, hepatitis b virus, host defense, intrinsic innate responses, IRF3, nuclear factor-kappaB, pattern recognition receptor",
author = "Emmanuel Thomas and Baumert, {Thomas F.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1055/s-0039-1685518",
language = "English (US)",
volume = "39",
pages = "301--314",
journal = "Seminars in Liver Disease",
issn = "0272-8087",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Hepatitis B Virus-Hepatocyte Interactions and Innate Immune Responses

T2 - Experimental Models and Molecular Mechanisms

AU - Thomas, Emmanuel

AU - Baumert, Thomas F.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide. While current therapeutic approaches can efficiently control viral infection, efficient curative antivirals are absent. The understanding of virus-hepatocyte interactions and sensing of viral infection is an important prerequisite for the development of novel antiviral therapies for cure. Hepatocyte intrinsic innate immunity provides a rapid first line of defense to combat viral infection through the upregulation of antiviral and inflammatory genes. However, the functional relevance of many of these antiviral signaling pathways in the liver and their role in HBV pathogenesis is still only partially understood. The recent identification of intracellular RNA and DNA sensing pathways and their involvement in disease biology, including viral pathogenesis and carcinogenesis, is currently transforming our understanding of virus-host interactions. Here the authors review the current knowledge on intrinsic antiviral innate immune responses including the role of viral nucleic acid sensing pathways in the liver. Since HBV has been designated as a stealth virus, the study of the impact of HBV on signaling pathways in the hepatocyte is of significant interest to understand viral pathogenesis. Characterizing the mechanism underlying these HBV-host interactions and targeting related pathways to enhance antiviral innate responses may open new strategies to trigger noncytopathic clearance of covalently closed circular DNA to ultimately cure patients with chronic HBV infection.

AB - Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide. While current therapeutic approaches can efficiently control viral infection, efficient curative antivirals are absent. The understanding of virus-hepatocyte interactions and sensing of viral infection is an important prerequisite for the development of novel antiviral therapies for cure. Hepatocyte intrinsic innate immunity provides a rapid first line of defense to combat viral infection through the upregulation of antiviral and inflammatory genes. However, the functional relevance of many of these antiviral signaling pathways in the liver and their role in HBV pathogenesis is still only partially understood. The recent identification of intracellular RNA and DNA sensing pathways and their involvement in disease biology, including viral pathogenesis and carcinogenesis, is currently transforming our understanding of virus-host interactions. Here the authors review the current knowledge on intrinsic antiviral innate immune responses including the role of viral nucleic acid sensing pathways in the liver. Since HBV has been designated as a stealth virus, the study of the impact of HBV on signaling pathways in the hepatocyte is of significant interest to understand viral pathogenesis. Characterizing the mechanism underlying these HBV-host interactions and targeting related pathways to enhance antiviral innate responses may open new strategies to trigger noncytopathic clearance of covalently closed circular DNA to ultimately cure patients with chronic HBV infection.

KW - antiviral immune responses

KW - chemokines

KW - cytokines

KW - hepatitis b virus

KW - host defense

KW - intrinsic innate responses

KW - IRF3

KW - nuclear factor-kappaB

KW - pattern recognition receptor

UR - http://www.scopus.com/inward/record.url?scp=85070332051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070332051&partnerID=8YFLogxK

U2 - 10.1055/s-0039-1685518

DO - 10.1055/s-0039-1685518

M3 - Article

VL - 39

SP - 301

EP - 314

JO - Seminars in Liver Disease

JF - Seminars in Liver Disease

SN - 0272-8087

IS - 3

ER -